Loading…

Committed memory effector type 2 cytotoxic T (Tc2) cells are ineffective in protective anti-tumor immunity

Cytotoxic CD8 + T cells (Tc) are a major effector cell population in protection against tumor growth and classified into Tc1 or Tc2 based on their cytokine-secreting profiles. However, their relative tumor protective roles remain undefined. In the present study, CD8 + memory T cells were obtained fr...

Full description

Saved in:
Bibliographic Details
Published in:Immunology letters 2004-08, Vol.95 (1), p.77-84
Main Authors: Do, Jeong-Su, Choi, Youn-Hwa, Shin, Sung-Hye, Yi, Ho Keun, Hwang, Pyung Han, Nam, Sang-Yun
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c355t-ac54eab270fd60efaacd364723743a48f5cdd64c8c809d3dec433efc546e6fad3
cites cdi_FETCH-LOGICAL-c355t-ac54eab270fd60efaacd364723743a48f5cdd64c8c809d3dec433efc546e6fad3
container_end_page 84
container_issue 1
container_start_page 77
container_title Immunology letters
container_volume 95
creator Do, Jeong-Su
Choi, Youn-Hwa
Shin, Sung-Hye
Yi, Ho Keun
Hwang, Pyung Han
Nam, Sang-Yun
description Cytotoxic CD8 + T cells (Tc) are a major effector cell population in protection against tumor growth and classified into Tc1 or Tc2 based on their cytokine-secreting profiles. However, their relative tumor protective roles remain undefined. In the present study, CD8 + memory T cells were obtained from mice given with CT26-IL 12 and tumor-specific Tc1 and Tc2 cells were induced by in vitro primary stimulation (1°). In vivo anti-tumor immunity and in vitro cytotoxicity of 1° Tc2 memory effector cells were highly protective comparably to 1° Tc1, but they secreted high level of IFNγ as well as IL 4 and IL 5. Moreover, memory cells obtained again from tumor-protected mice by either 1° Tc1 or Tc2 transfer showed indistinguishable, Tc1-like, cytokine profiles. These results strongly suggest that 1° Tc2 cells are insufficiently polarized. Tc2 memory effector cells were therefore examined for their transitional anti-tumor activity during consecutive stimulation until Th2 commitment. Secondary stimulation (2°) markedly reduced secretion of IFNγ (by 94%) and in vivo tumor protection (by 83%). Tertiary (3°) and further stimulation completely abrogated both of tumor protective activity and IFNγ secretion of Tc2 cells. This progressive loss of activity following repeated stimulation was accompanied by a reduction of in vitro cytotoxicity to CT26 tumor cells. In addition, when 1° Tc2 cells were trans-differentiated to Tc1 during secondary stimulation, 2 of 6 cultures recovered tumor protective activity concomitantly with IFNγ secretion, indicating that repeated stimulation does not deteriorate tumor protective activity of 2° Tc2 cells. Collectively, these data demonstrate that highly committed Tc2 cells are ineffective in tumor protection.
doi_str_mv 10.1016/j.imlet.2004.06.006
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_17729518</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0165247804001646</els_id><sourcerecordid>17729518</sourcerecordid><originalsourceid>FETCH-LOGICAL-c355t-ac54eab270fd60efaacd364723743a48f5cdd64c8c809d3dec433efc546e6fad3</originalsourceid><addsrcrecordid>eNp9kM1qGzEUhUVpaZy0TxAoWpVkMVP9z3iRRTD9g0A3zloo0hXIWCNX0oTM20eODd11dSX4ztHVh9A1JT0lVH3b9SHuofaMENET1ROi3qEVHYd1R6Rg79GqUbJjYhgv0GUpO0Ko5IJ_RBdtMjkSukK7TYox1AoOR4gpLxi8B1tTxnU5AGbYLjXV9BIs3uKbrWW32MJ-X7DJgMN0osPz8YwPOdXzzUw1dHVujTjEOE-hLp_QB2_2BT6f5xV6_PF9u_nVPfz5-Xtz_9BZLmXtjJUCzBMbiHeKgDfGOq7EwPgguBGjl9Y5JexoR7J23IEVnINvKQXKG8ev0NdTb1vn7wyl6hjKcWczQZqLpsPA1pKODeQn0OZUSgavDzlEkxdNiT4q1jv9plgfFWuidFPcUl_O9fNTBPcvc3bagLsTAO2TzwGyLjbAZMGF3Oxol8J_H3gFT_WQLQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17729518</pqid></control><display><type>article</type><title>Committed memory effector type 2 cytotoxic T (Tc2) cells are ineffective in protective anti-tumor immunity</title><source>ScienceDirect Journals</source><creator>Do, Jeong-Su ; Choi, Youn-Hwa ; Shin, Sung-Hye ; Yi, Ho Keun ; Hwang, Pyung Han ; Nam, Sang-Yun</creator><creatorcontrib>Do, Jeong-Su ; Choi, Youn-Hwa ; Shin, Sung-Hye ; Yi, Ho Keun ; Hwang, Pyung Han ; Nam, Sang-Yun</creatorcontrib><description>Cytotoxic CD8 + T cells (Tc) are a major effector cell population in protection against tumor growth and classified into Tc1 or Tc2 based on their cytokine-secreting profiles. However, their relative tumor protective roles remain undefined. In the present study, CD8 + memory T cells were obtained from mice given with CT26-IL 12 and tumor-specific Tc1 and Tc2 cells were induced by in vitro primary stimulation (1°). In vivo anti-tumor immunity and in vitro cytotoxicity of 1° Tc2 memory effector cells were highly protective comparably to 1° Tc1, but they secreted high level of IFNγ as well as IL 4 and IL 5. Moreover, memory cells obtained again from tumor-protected mice by either 1° Tc1 or Tc2 transfer showed indistinguishable, Tc1-like, cytokine profiles. These results strongly suggest that 1° Tc2 cells are insufficiently polarized. Tc2 memory effector cells were therefore examined for their transitional anti-tumor activity during consecutive stimulation until Th2 commitment. Secondary stimulation (2°) markedly reduced secretion of IFNγ (by 94%) and in vivo tumor protection (by 83%). Tertiary (3°) and further stimulation completely abrogated both of tumor protective activity and IFNγ secretion of Tc2 cells. This progressive loss of activity following repeated stimulation was accompanied by a reduction of in vitro cytotoxicity to CT26 tumor cells. In addition, when 1° Tc2 cells were trans-differentiated to Tc1 during secondary stimulation, 2 of 6 cultures recovered tumor protective activity concomitantly with IFNγ secretion, indicating that repeated stimulation does not deteriorate tumor protective activity of 2° Tc2 cells. Collectively, these data demonstrate that highly committed Tc2 cells are ineffective in tumor protection.</description><identifier>ISSN: 0165-2478</identifier><identifier>EISSN: 1879-0542</identifier><identifier>DOI: 10.1016/j.imlet.2004.06.006</identifier><identifier>PMID: 15325801</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Animals ; Anti-tumor activity ; CD4-Positive T-Lymphocytes - immunology ; CD8 ; Cell Line, Tumor ; Colonic Neoplasms - immunology ; Colonic Neoplasms - prevention &amp; control ; Cytokines - biosynthesis ; Cytotoxicity, Immunologic ; Immunity, Cellular ; Immunologic Memory ; Male ; Memory cells ; Mice ; Mice, Inbred BALB C ; Neoplasm Transplantation ; Neoplasms, Experimental - immunology ; T cells ; T-Lymphocyte Subsets - immunology ; T-Lymphocytes, Cytotoxic - immunology ; Tc1/Tc2 cells</subject><ispartof>Immunology letters, 2004-08, Vol.95 (1), p.77-84</ispartof><rights>2004 Elsevier B.V.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c355t-ac54eab270fd60efaacd364723743a48f5cdd64c8c809d3dec433efc546e6fad3</citedby><cites>FETCH-LOGICAL-c355t-ac54eab270fd60efaacd364723743a48f5cdd64c8c809d3dec433efc546e6fad3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15325801$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Do, Jeong-Su</creatorcontrib><creatorcontrib>Choi, Youn-Hwa</creatorcontrib><creatorcontrib>Shin, Sung-Hye</creatorcontrib><creatorcontrib>Yi, Ho Keun</creatorcontrib><creatorcontrib>Hwang, Pyung Han</creatorcontrib><creatorcontrib>Nam, Sang-Yun</creatorcontrib><title>Committed memory effector type 2 cytotoxic T (Tc2) cells are ineffective in protective anti-tumor immunity</title><title>Immunology letters</title><addtitle>Immunol Lett</addtitle><description>Cytotoxic CD8 + T cells (Tc) are a major effector cell population in protection against tumor growth and classified into Tc1 or Tc2 based on their cytokine-secreting profiles. However, their relative tumor protective roles remain undefined. In the present study, CD8 + memory T cells were obtained from mice given with CT26-IL 12 and tumor-specific Tc1 and Tc2 cells were induced by in vitro primary stimulation (1°). In vivo anti-tumor immunity and in vitro cytotoxicity of 1° Tc2 memory effector cells were highly protective comparably to 1° Tc1, but they secreted high level of IFNγ as well as IL 4 and IL 5. Moreover, memory cells obtained again from tumor-protected mice by either 1° Tc1 or Tc2 transfer showed indistinguishable, Tc1-like, cytokine profiles. These results strongly suggest that 1° Tc2 cells are insufficiently polarized. Tc2 memory effector cells were therefore examined for their transitional anti-tumor activity during consecutive stimulation until Th2 commitment. Secondary stimulation (2°) markedly reduced secretion of IFNγ (by 94%) and in vivo tumor protection (by 83%). Tertiary (3°) and further stimulation completely abrogated both of tumor protective activity and IFNγ secretion of Tc2 cells. This progressive loss of activity following repeated stimulation was accompanied by a reduction of in vitro cytotoxicity to CT26 tumor cells. In addition, when 1° Tc2 cells were trans-differentiated to Tc1 during secondary stimulation, 2 of 6 cultures recovered tumor protective activity concomitantly with IFNγ secretion, indicating that repeated stimulation does not deteriorate tumor protective activity of 2° Tc2 cells. Collectively, these data demonstrate that highly committed Tc2 cells are ineffective in tumor protection.</description><subject>Animals</subject><subject>Anti-tumor activity</subject><subject>CD4-Positive T-Lymphocytes - immunology</subject><subject>CD8</subject><subject>Cell Line, Tumor</subject><subject>Colonic Neoplasms - immunology</subject><subject>Colonic Neoplasms - prevention &amp; control</subject><subject>Cytokines - biosynthesis</subject><subject>Cytotoxicity, Immunologic</subject><subject>Immunity, Cellular</subject><subject>Immunologic Memory</subject><subject>Male</subject><subject>Memory cells</subject><subject>Mice</subject><subject>Mice, Inbred BALB C</subject><subject>Neoplasm Transplantation</subject><subject>Neoplasms, Experimental - immunology</subject><subject>T cells</subject><subject>T-Lymphocyte Subsets - immunology</subject><subject>T-Lymphocytes, Cytotoxic - immunology</subject><subject>Tc1/Tc2 cells</subject><issn>0165-2478</issn><issn>1879-0542</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><recordid>eNp9kM1qGzEUhUVpaZy0TxAoWpVkMVP9z3iRRTD9g0A3zloo0hXIWCNX0oTM20eODd11dSX4ztHVh9A1JT0lVH3b9SHuofaMENET1ROi3qEVHYd1R6Rg79GqUbJjYhgv0GUpO0Ko5IJ_RBdtMjkSukK7TYox1AoOR4gpLxi8B1tTxnU5AGbYLjXV9BIs3uKbrWW32MJ-X7DJgMN0osPz8YwPOdXzzUw1dHVujTjEOE-hLp_QB2_2BT6f5xV6_PF9u_nVPfz5-Xtz_9BZLmXtjJUCzBMbiHeKgDfGOq7EwPgguBGjl9Y5JexoR7J23IEVnINvKQXKG8ev0NdTb1vn7wyl6hjKcWczQZqLpsPA1pKODeQn0OZUSgavDzlEkxdNiT4q1jv9plgfFWuidFPcUl_O9fNTBPcvc3bagLsTAO2TzwGyLjbAZMGF3Oxol8J_H3gFT_WQLQ</recordid><startdate>20040815</startdate><enddate>20040815</enddate><creator>Do, Jeong-Su</creator><creator>Choi, Youn-Hwa</creator><creator>Shin, Sung-Hye</creator><creator>Yi, Ho Keun</creator><creator>Hwang, Pyung Han</creator><creator>Nam, Sang-Yun</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope></search><sort><creationdate>20040815</creationdate><title>Committed memory effector type 2 cytotoxic T (Tc2) cells are ineffective in protective anti-tumor immunity</title><author>Do, Jeong-Su ; Choi, Youn-Hwa ; Shin, Sung-Hye ; Yi, Ho Keun ; Hwang, Pyung Han ; Nam, Sang-Yun</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c355t-ac54eab270fd60efaacd364723743a48f5cdd64c8c809d3dec433efc546e6fad3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Animals</topic><topic>Anti-tumor activity</topic><topic>CD4-Positive T-Lymphocytes - immunology</topic><topic>CD8</topic><topic>Cell Line, Tumor</topic><topic>Colonic Neoplasms - immunology</topic><topic>Colonic Neoplasms - prevention &amp; control</topic><topic>Cytokines - biosynthesis</topic><topic>Cytotoxicity, Immunologic</topic><topic>Immunity, Cellular</topic><topic>Immunologic Memory</topic><topic>Male</topic><topic>Memory cells</topic><topic>Mice</topic><topic>Mice, Inbred BALB C</topic><topic>Neoplasm Transplantation</topic><topic>Neoplasms, Experimental - immunology</topic><topic>T cells</topic><topic>T-Lymphocyte Subsets - immunology</topic><topic>T-Lymphocytes, Cytotoxic - immunology</topic><topic>Tc1/Tc2 cells</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Do, Jeong-Su</creatorcontrib><creatorcontrib>Choi, Youn-Hwa</creatorcontrib><creatorcontrib>Shin, Sung-Hye</creatorcontrib><creatorcontrib>Yi, Ho Keun</creatorcontrib><creatorcontrib>Hwang, Pyung Han</creatorcontrib><creatorcontrib>Nam, Sang-Yun</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><jtitle>Immunology letters</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Do, Jeong-Su</au><au>Choi, Youn-Hwa</au><au>Shin, Sung-Hye</au><au>Yi, Ho Keun</au><au>Hwang, Pyung Han</au><au>Nam, Sang-Yun</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Committed memory effector type 2 cytotoxic T (Tc2) cells are ineffective in protective anti-tumor immunity</atitle><jtitle>Immunology letters</jtitle><addtitle>Immunol Lett</addtitle><date>2004-08-15</date><risdate>2004</risdate><volume>95</volume><issue>1</issue><spage>77</spage><epage>84</epage><pages>77-84</pages><issn>0165-2478</issn><eissn>1879-0542</eissn><abstract>Cytotoxic CD8 + T cells (Tc) are a major effector cell population in protection against tumor growth and classified into Tc1 or Tc2 based on their cytokine-secreting profiles. However, their relative tumor protective roles remain undefined. In the present study, CD8 + memory T cells were obtained from mice given with CT26-IL 12 and tumor-specific Tc1 and Tc2 cells were induced by in vitro primary stimulation (1°). In vivo anti-tumor immunity and in vitro cytotoxicity of 1° Tc2 memory effector cells were highly protective comparably to 1° Tc1, but they secreted high level of IFNγ as well as IL 4 and IL 5. Moreover, memory cells obtained again from tumor-protected mice by either 1° Tc1 or Tc2 transfer showed indistinguishable, Tc1-like, cytokine profiles. These results strongly suggest that 1° Tc2 cells are insufficiently polarized. Tc2 memory effector cells were therefore examined for their transitional anti-tumor activity during consecutive stimulation until Th2 commitment. Secondary stimulation (2°) markedly reduced secretion of IFNγ (by 94%) and in vivo tumor protection (by 83%). Tertiary (3°) and further stimulation completely abrogated both of tumor protective activity and IFNγ secretion of Tc2 cells. This progressive loss of activity following repeated stimulation was accompanied by a reduction of in vitro cytotoxicity to CT26 tumor cells. In addition, when 1° Tc2 cells were trans-differentiated to Tc1 during secondary stimulation, 2 of 6 cultures recovered tumor protective activity concomitantly with IFNγ secretion, indicating that repeated stimulation does not deteriorate tumor protective activity of 2° Tc2 cells. Collectively, these data demonstrate that highly committed Tc2 cells are ineffective in tumor protection.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>15325801</pmid><doi>10.1016/j.imlet.2004.06.006</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0165-2478
ispartof Immunology letters, 2004-08, Vol.95 (1), p.77-84
issn 0165-2478
1879-0542
language eng
recordid cdi_proquest_miscellaneous_17729518
source ScienceDirect Journals
subjects Animals
Anti-tumor activity
CD4-Positive T-Lymphocytes - immunology
CD8
Cell Line, Tumor
Colonic Neoplasms - immunology
Colonic Neoplasms - prevention & control
Cytokines - biosynthesis
Cytotoxicity, Immunologic
Immunity, Cellular
Immunologic Memory
Male
Memory cells
Mice
Mice, Inbred BALB C
Neoplasm Transplantation
Neoplasms, Experimental - immunology
T cells
T-Lymphocyte Subsets - immunology
T-Lymphocytes, Cytotoxic - immunology
Tc1/Tc2 cells
title Committed memory effector type 2 cytotoxic T (Tc2) cells are ineffective in protective anti-tumor immunity
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T05%3A38%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Committed%20memory%20effector%20type%202%20cytotoxic%20T%20(Tc2)%20cells%20are%20ineffective%20in%20protective%20anti-tumor%20immunity&rft.jtitle=Immunology%20letters&rft.au=Do,%20Jeong-Su&rft.date=2004-08-15&rft.volume=95&rft.issue=1&rft.spage=77&rft.epage=84&rft.pages=77-84&rft.issn=0165-2478&rft.eissn=1879-0542&rft_id=info:doi/10.1016/j.imlet.2004.06.006&rft_dat=%3Cproquest_cross%3E17729518%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c355t-ac54eab270fd60efaacd364723743a48f5cdd64c8c809d3dec433efc546e6fad3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=17729518&rft_id=info:pmid/15325801&rfr_iscdi=true